Loading clinical trials...
Loading clinical trials...
This study will evaluate the impact of investigator and patient education and educational materials to foster calcium and vitamin D supplementation to mitigate the potential for hypocalcemia post Recl...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT05573828 · Iatrogenic Hypocalcemia
NCT06065852 · Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, and more
NCT05585593 · Comorbidities and Coexisting Conditions, Morality, and more
NCT05680818 · Autosomal Dominant Hypocalcemia (ADH)
NCT05227287 · Autosomal Dominant Hypocalcemia
Novartis Investigative Site
Phoenix, Arizona
Novartis Investigative Site
Tucson, Arizona
Novartis Investigative Site
Gainesville, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions